Anthony B James

US Patent:

7983777, Jul 19, 2011

Filed:

Aug 18, 2006

Appl. No.:

11/506575

Inventors:

Mark Melton - Carlsbad CA, US
Anthony James - Bartlett TN, US
Steve Bruneau - Edgewater Park NJ, US
Thomas W. Rassmann - Marlton NJ, US
Jonathan D. Langlois - Wilton NY, US

International Classification:

G06F 19/00
G06Q 30/00
A61F 2/82

US Classification:

700 98, 700118, 705 265, 623 115

Abstract:

Automated systems and methods for creating and obtaining devices, including biomedical implants. Systems can have a surgeon's device, an automated platform, and a server. The surgeon's device can send a request for a template of a biomedical implant, and can access tools to edit the template. The automated platform can receive the edited template, and can generate a response. The response can include translating the edited template into a design for a biomedical implant. The response can further include generating a notice if the edited template falls outside of an acceptable range, or if the edited template is similar to the design of a standard biomedical implant. There can also be provided a manufacturing facility that can manufacture the implant and send the implant to the surgeon.

US Patent:

20100332197, Dec 30, 2010

Filed:

Jul 20, 2010

Appl. No.:

12/839433

Inventors:

Mark Melton - Carlsbad CA, US
Anthony James - Bartlett TN, US
Steve Bruneau - Edgewater Park NJ, US
Thomas W. Rassmann - Marlton NJ, US
Jonathan D. Langlois - Wilton NY, US

International Classification:

G06F 17/50

US Classification:

703 1

Abstract:

Automated systems and methods for creating and obtaining devices, including biomedical implants. Systems can have a surgeon's device, an automated platform, and a server. The surgeon's device can send a request for a template of a biomedical implant, and can access tools to edit the template. The automated platform can receive the edited template, and can generate a response. The response can include translating the edited template into a design for a biomedical implant. The response can further include generating a notice if the edited template falls outside of an acceptable range, or if the edited template is similar to the design of a standard biomedical implant. There can also be provided a manufacturing facility that can manufacture the implant and send the implant to the surgeon.

US Patent:

20210000091, Jan 7, 2021

Filed:

Aug 17, 2017

Appl. No.:

16/325110

Inventors:

- OAKLAND CA, US
Valentino Gantz - San Diego CA, US
Anthony A. James - Irvine CA, US

International Classification:

A01K 67/033
C12N 9/22

Abstract:

Provided are systems, constructs, genetically modified organisms, and methods for greatly reducing or eliminating local populations of mosquitoes, and associated Dengue fever, yellow fever, Zika virus, and Chikungunya virus. Provided are genetically modified having a Cas9-mediated split gene-drive system for masculinizing the mosquito and ensuring that any female carries a sterile mutation. In addition, gRNAs direct Cas9 cleavage of insecticide-resistance loci, rendering female mosquitoes escaping the male converting gene drive sensitive to insecticides.